Hello, Thanks for signing up for MarketBeat Daily Ratings—we’re excited to have you on board. Every weekday, you’ll get a curated summary of new “Buy” and “Sell” ratings from Wall Street’s top-rated analysts, the latest stock news, and bonus investing content—all delivered straight to your inbox. You’re just two quick steps away from completing your sign-up: 1. Make sure our emails go to your inbox Gmail users:
Mobile: Tap the three dots (…) in the top right and select Move to Inbox or Move to Primary
Desktop: Click the folder icon at the top and select Move to Inbox or Primary Apple Mail users:
Tap our email address at the top (next to From: on mobile), then select Add to VIP Other providers:
Reply to this message and add newsletters@analystratings.net to your contacts 2. Confirm your subscription Click this link to confirm your subscription. This verifies your account and ensures you receive your newsletters without interruption instead of getting stuck in your spam filter. Confirm your subscription here. After you confirm, feel free to download our popular free report, "7 Stocks to Buy and Hold Forever" with this link. Thanks again for subscribing—we look forward to being part of your investing journey. 
Matthew Paulson
Founder and CEO, MarketBeat. P.S. If you didn’t mean to subscribe, no problem—you can unsubscribe here.
This Week's Exclusive News Why Amprius Insiders Are Selling—and Why Bulls Aren't PanickingAuthored by Thomas Hughes. Date Posted: 1/26/2026. 
Summary - Amprius Technologies insider selling was executed under a 10b5-1 plan, and insiders still own nearly 13% of the company.
- Institutional interest and analyst sentiment remain supportive, with improving accumulation and a Buy-leaning rating mix.
- NDAA-compliant capacity expansion, strong revenue growth expectations, and easing short interest set up catalysts ahead.
Amprius Technologies (NYSE: AMPX) insiders, led by CTO Constantin Stefan, have been selling shares. That activity isn't necessarily a red flag: the sales were executed under 10b5-1 trading plans—prearranged programs that allow insiders to sell stock periodically, often tied to share-based compensation. With AMPX up more than 400% from its 2025 lows as of late January 2026, insiders have reasonable motives to realize gains, including portfolio diversification and managing tax liabilities from option exercises. The key point is that insiders still own nearly 13% of the company, and other indicators—such as institutional and analyst trends—suggest accumulation despite insider selling. Institutional ownership remains relatively low but has been creeping higher, with activity ramping up at the end of 2025. In Q4, buying outpaced selling by more than $27 for every $1 sold, and that bullish bias carried into early 2026. The former CEO of Google calls it the most important thing to happen in 500, maybe 1,000 years of human society. A former U.S. Treasury Secretary says when your great-grandchildren write the history of this period, the political headlines will be the second or third story. The first story is something none of us have seen before. The dot-com collapse, global financial crisis, and COVID-19 pandemic don't compare to what's coming next. We may be entering a period of dramatic, almost unimaginable change. See the full warning and how to prepare now. Seven reports support the Moderate Buy rating, and the consensus shows a strongly bullish tilt—85% of ratings are Buy, with the only outlier a Sell from Weiss Ratings. Analysts see more than 40% upside from key support levels at the consensus, and there is potential for the stock to move toward the high end of the range, possibly as high as $20, within the next few quarters. 
Amprius Technologies Strengthens Capacity, Reduces Costs in Late 2025 Amprius has been focused on lowering costs while scaling production. In mid-2025 the company paused construction of domestic manufacturing facilities to expand its contract-manufacturing network. Working with South Korean contract manufacturers helps the company expand capacity in an asset-light way while maintaining National Defense Authorization Act (NDAA) compliance—an important consideration given that Amprius' primary markets as of early 2026 are defense-related, including drones, unmanned vehicles and man-portable systems. The upcoming Q4 2025 and subsequent earnings reports are likely catalysts for the stock. The company is expected to report Q4 revenue growth of more than 120%, though consensus targets may still lag the underlying momentum. All analysts raised their Q4 revenue estimates following the Q3 earnings report, reflecting growing traction. Longer-term forecasts may also be conservative given the disruptive potential of silicon‑anode lithium‑ion technology, setting the stage for a persistent bullish revision cycle over the coming quarters and years. Short Covering Signals Bottom in the AMPX Market Short selling played a major role in AMPX's correction in late 2025. Short interest spiked above 20%, reaching record levels. By late January 2026, short interest had retreated from that peak—down roughly 22% sequentially—and that decline coincided with a market bottom forming at year-end. If short covering continues and upcoming results are solid, the 2026 rebound should gain momentum and could retest long-term highs near $16 early in the year. If it doesn't, the stock may remain range-bound with a risk of a deeper correction. For now, AMPX appears to be in rebound mode. The stock is up significantly from the late-2025 low and has moved above a key resistance level. January price action suggests that resistance is turning into support, which could position the stock to continue its advance. In that scenario, AMPX could retest its long-term high near $16 before the March earnings report, though it may struggle to set new highs until that report or another catalyst emerges.
| 
0 Response to "We're excited to have you on board"
Post a Comment